详情页

资源类型：

文章类型：

作者：

Jiang Zefei[1] * ; Ouyang Quchang[2] ; Sun Tao[3] ; Zhang Qingyuan[4] ; Teng Yuee[5] ; Cui Jiuwei[6] ; Wang Haibo[7] ; Yin Yongmei[8] ; Wang Xiaojia[9] ; Zhou Xin[10] ; Wang Yongsheng[11] ; Sun Gang[12] ; Wang Jingfen[13] ; Zhang Lili[14] ; Yang Jin[15] ; Qian Jun[16] ; Yan Min[17] ; Liu Xinlan[18] ; Yi Tienan[19] ; Cheng Ying[20] ; Li Man[21] ; Zang Aimin[22] ; Wang Shusen[23] ; Wang Chuan[24] ; Wu Xinhong[25] ; Cheng Jing[26] ; Li Hui[27] ; Lin Ying[28] ; Geng Cuizhi[29]

; Gu Kangsheng[30] ; Xie Chunwei[31] ; Xiong Huihua[32] ; Wu Xiaohong[33] ; Yang Junlan[34] ; Li Qingshan[35] ; Chen Yiding[36] ; Li Fanfan[37] ; Zhang Anqin[38] ; Zhang Yongqiang[39] ; Wu Yudong[40] ; Nie Jianyun[41] ; Liu Qiang[42] ; Wang Kun[43] ; Mo Xueli[44] ; Chen Lilin[45] ; Pan Yueyin[46] ; Fu Peifen[47] ; Zhang Helong[48] ; Pang Danmei[49] ; Sheng Yuan[50] ; Han Yunwei[51] ; Wang Hongxia[52,53] ; Cang Shundong[54] ; Luo Xianming[55] ; Yu Wenbo[55] ; Deng Rong[55] ; Yang Chaoqiang[55] ; Keegan Patricia[56] ;

机构： [1]Fifth Medical Center of Chinese PLA General Hospital, Beijing, China. [2]Breast Internal Medicine Department, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China. [3]Breast Medicine Ward Area I, Liaoning Cancer Hospital, Shenyang, China. [4]Department of Breast & Lymphoma, Harbin Medical University Cancer Hospital, Harbin, China. [5]Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China. [6]Oncology Center, Oncology Department, The First Hospital of Jilin University, Changchun, China. [7]Breast Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China. [8]Department of Oncology, Jiangsu Province Hospital, Nanjing, China. [9]Department of Breast (Mammary Gland) Disease, Zhejiang Cancer Hospital, Hangzhou, China. [10]The Breast Cancer Center, Chongqing University Cancer Hospital, Chongqing, China. [11]Breast Surgery, Shandong Cancer Hospital, Jinan, China. [12]Breast Medicine Department, Xinjiang Medical University Affiliated Cancer Hospital, Urumqi, China. [13]Breast Medicine Department, Linyi Cancer Hospital, Linyi, China. [14]Department of Oncology, Jiangsu Cancer Hospital, Nanjing, China. [15]Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. [16]Department of Surgical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China. [17]Breast Surgery, Henan Cancer Hospital, Zhengzhou, China. [18]Department of Medical Oncology, General Hospital of Ningxia Medical University, Yinchuan, China. [19]Department of Oncology, Xiangyang Central Hospital, Xiangyang, China. [20]Department of Medical Oncology, Jilin Cancer Hospital, Changchun, China. [21]Department of Medical Oncology, The Second Hospital of Dalian Medical University, Dalian, China. [22]Department of Medical Oncology, Affiliated Hospital of Hebei University, Baoding, China. [23]Internal Medicine Department, Sun Yat-sen University Cancer Center, Guangzhou, China. [24]Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, China. [25]Galactophore Department, Hubei Cancer Hospital, Wuhan, China. [26]Galactophore Department, Union Hospital Tongji Medical College of Hust, Wuhan, China. [27]Breast Surgery, Sichuan Cancer Hospital, Chengdu, China. [28]Breast Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. [29]Department of Breast Cancer, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. [30]Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China. [31]Breast Surgery, Nanchang People's Hospital, Nanchang, China. [32]Department of Oncology, Tongji Hospital Tongji Medical College of Hust, Wuhan, China. [33]Department of Oncology, Affiliated Hospital of Jiangnan University, Wuxi, China. [34]Department of Medical Oncology, The First Medical Center of the General Hospital of the People's Liberation Army of China, Beijing, China. [35]Department of Oncology, Affiliated Hospital of Chengde Medical University, Chengde, China. [36]Breast Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. [37]Department of Oncology, The Second Affiliated Hospital of Anhui University, Hefei, China. [38]Breast Surgery Department, Guandong Maternal Hospital, Guandong Children's Hospital, Guangzhou, China. [39]Department of Medical Oncology, Beijing Hospital, Beijing, China. [40]Breast Surgery, Jiangxi Cancer Hospital, Nanchang, China. [41]Third Department of Breast Surgery, Yunnan Cancer Hospital (The Third Affiliated Hospital of Kunming Medical University), Kuming, China. [42]Breast Surgery Department, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. [43]Department of Breast Oncology, Guangdong Provincial People's Hospital, Guangzhou, China. [44]Breast Disease Department, Peking University Shougang Hospital, Beijing, China. [45]Department of Medical Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China. [46]Oncology Chemotherapy Department, First Affiliated Hospital of USTC (Anhui Provincial Hospital), Hefei, China. [47]Breast Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. [48]Department of Medical Oncology, The Second Affiliated Hospital of the Air Force Medical University of the People's Liberation Army Chinese People's Liberation Army, Xi'an, China. [49]Breast Oncology Department, The First People's Hospital of Foshan, Foshan, China. [50]Thyroid and Breast Surgery Department, Changhai Hospital of Shanghai, Shanghai, China. [51]Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, China. [52]Department of Oncology, Shanghai General Hospital, Shanghai, China. [53]Fudan University Shanghai Cancer Center, Shanghai, China. [54]Department of Medical Oncology, Henan Provincial People's Hospital, Zhengzhou, China. [55]Shanghai Junshi Biosciences, Shanghai, China. [56]TopAlliance Biosciences, Rockville, MD, USA.

出处：

DOI：

ISSN：

基金：

语种：

WOS：

PubmedID：

中科院分区：

出版当年[2025]版：

大类 | 4 区医学

小类 | 4 区肿瘤学

最新[2025]版：

大类 | 4 区医学

小类 | 4 区肿瘤学

JCR分区：

出版当年[2024]版：

Q3 ONCOLOGY

最新[2024]版：

Q3 ONCOLOGY

第一作者：

第一作者机构： [1]Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

A plain language summary of results from the TORCHLIGHT trial of toripalimab plus chemotherapy for metastatic or recurrent triple-negative breast cancer

文献详情